AJTMH ASTMH MEMBERSHIP INFORMATION: astmh@astmh.org
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 64(1), 2001, pp. 24-27
Copyright © 2001 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chetchotisakd, P
Right arrow Articles by Thinkamrop, B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chetchotisakd, P
Right arrow Articles by Thinkamrop, B
Related Collections
Right arrow Travel Medicine
Right arrow Melioidosis
American Journal of Tropical Medicine and Hygiene, Vol 64, Issue 1, 24-27
Copyright © 2001 by American Society of Tropical Medicine and Hygiene

Research Articles


Maintenance therapy of melioidosis with ciprofloxacin plus azithromycin compared with cotrimoxazole plus doxycycline

P Chetchotisakd, W Chaowagul, P Mootsikapun, D Budhsarawong, and B Thinkamrop

This is a report of a randomized, open, labeled study of the maintenance treatment of melioidosis using a combination of ciprofloxacin and azithromycin (Regimen A) for 12 weeks versus a combination of cotrimoxazole and doxycycline (Regimen B) for 20 weeks. The study was conducted at two tertiary-care hospitals in northeast Thailand. A total 65 patients were enrolled, 36 and 29, respectively, between August 1997 and July 1998. Subjects were randomly allocated to each arm of the trial, resulting in 32 treated under Regimen A and 33 in B. The main outcome was a culture-proven relapse in melioidosis. There were more relapses under Regimen A at 22% (7 of 32) than in Regimen B, 3% (1 of 33). The 19% difference in the rates was significant (95% confidence interval [CI]: 3% to 34%; exact P-value = 0.027). Based on our data, a combination of cotrimoxazole and doxycycline treatment for 20 weeks should be given further consideration as the maintenance therapy of choice for melioidosis.


This article has been cited by other articles:


Home page
 J. Clin. Microbiol.Home page
B. Maharjan, N. Chantratita, M. Vesaratchavest, A. Cheng, V. Wuthiekanun, W. Chierakul, W. Chaowagul, N. P. J. Day, and S. J. Peacock
Recurrent Melioidosis in Patients in Northeast Thailand Is Frequently Due to Reinfection Rather than Relapse
J. Clin. Microbiol., December 1, 2005; 43(12): 6032 - 6034.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
W. Chaowagul, W. Chierakul, A. J. Simpson, J. M. Short, K. Stepniewska, B. Maharjan, A. Rajchanuvong, D. Busarawong, D. Limmathurotsakul, A. C. Cheng, et al.
Open-Label Randomized Trial of Oral Trimethoprim-Sulfamethoxazole, Doxycycline, and Chloramphenicol Compared with Trimethoprim-Sulfamethoxazole and Doxycycline for Maintenance Therapy of Melioidosis
Antimicrob. Agents Chemother., October 1, 2005; 49(10): 4020 - 4025.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
A. C. Cheng and B. J. Currie
Melioidosis: Epidemiology, Pathophysiology, and Management
Clin. Microbiol. Rev., April 1, 2005; 18(2): 383 - 416.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
J. Steward, T. Piercy, M. S. Lever, M. Nelson, A. J. H. Simpson, and T. J. G. Brooks
Comparison of gatifloxacin, moxifloxacin and ciprofloxacin for treatment of experimental Burkholderia pseudomallei infection
J. Antimicrob. Chemother., April 1, 2005; 55(4): 523 - 527.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
F. M. Thibault, E. Hernandez, D. R. Vidal, M. Girardet, and J.-D. Cavallo
Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents
J. Antimicrob. Chemother., December 1, 2004; 54(6): 1134 - 1138.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society of Tropical Medicine and Hygiene.